BioNTech SE is 3.5x more valuable than Apogee Therapeutics, Inc. by market capitalization ($22.90 B vs $6.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | APGE | BNTX |
|---|---|---|
| Market cap | $6.61 B | $22.90 B |
| US-listed rank | #1209 | #572 |
| Net income (latest FY) | -$255.84M | - |
| SEC filings | 262 | 548 |
BioNTech SE is 3.5x more valuable than Apogee Therapeutics, Inc. by market capitalization ($22.90 B vs $6.61 B).
Full pages: Apogee Therapeutics, Inc. and BioNTech SE, or browse the full rankings.